Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.

Cell metabolism - 2 Mar 2021

Drucker Daniel J

Abstract excerpt

The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people hospitalized with severe COVID-19 illness has engendered considerable interest in the metabolic aspects of SARS-CoV-2-induced pathophysiology. Here, I update concepts informing how metabolic disorders and their co-morbidities modify the susceptibility to, natural history, and potential treatment of SARS-CoV-2 infection, with...

Topics

Angiotensin-Converting Enzyme 2
Blood Glucose
COVID-19
Cholesterol
Comorbidity
Diabetes Mellitus
Genetic Predisposition to Disease
Glucose
Heart Disease Risk Factors
Humans
Hyperglycemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Metabolic Diseases

Obesity

SARS-CoV-2

COVID-19 Drug Treatment

Source

Open in PubMed Open full text

Identifiers

PMID: 33529600
DOI: 10.1016/j.cmet.2021.01.016
PMCID: PMC7825982

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.PMID 33529600Read ↗

Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.Semantic proximity Read ↗

Regulation of angiotensin converting enzyme 2 (ACE2) in obesity: implications for COVID-19Semantic proximity Read ↗

The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review.Semantic proximity Read ↗

Recent Progress in Metabolic Syndrome Research and TherapeuticsSemantic proximity Read ↗

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers.Semantic proximity Read ↗

Obesity and its impact on COVID-19Semantic proximity Read ↗

Examination of the Complex Molecular Landscape in Obesity and Type 2 DiabetesSemantic proximity Read ↗

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implicationsSemantic proximity Read ↗

An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and SeveritySemantic proximity Read ↗

Genetic Susceptibility of Type 2 Diabetes and Metabolic SyndromeSemantic proximity Read ↗

Replication of SARS-CoV-2 in Adipose Tissue Determines Organ and Systemic Lipid Metabolism in Hamsters and HumansSemantic proximity Read ↗

Diet induced obesity and type 2 diabetes drives exacerbated sex-associated disease profiles in K18-hACE2-mice challenged with SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.